EUCR
Eucrates Biomedical Acquisition
EUCR | NASDAQ
$10.04
$0.00 (0.00%)
At close: Apr 26, 2023, 03:14 PM ET
+0.00%
(1D)Rating
Key Statistics
Market Data
Market Cap $42.23M
1D Range
10.02 10.04
52W Range
9.87 10.25
Valuation (TTM)
PE 18.25
PB 4.95
EV/EBITDA -115.44
Valuation (NTM)
Forward PE N/A
Forward PEG -0.13
Price Target N/A
Cash Flow
FCF Yield -1.5%
SBC Adj. FCF Yield -1.5%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y N/A |
N/A
FCF 3Y | 5Y N/A |
N/A
Returns
ROA 44.4%
ROE 10.3%
ROIC -5.6%
Financial Health
Net Cash
$18.87K
Current Ratio 2.03
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity ...
Sector Financial Services
Industry Shell Companies
Employees n/a
IPO Date Dec 28, 2020
Website n/a
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove EUCR